Home › Companies › Biotechnology, Genetics, Health Diagnostics, Life Science, Oncology, Pharmaceutical, Therapeutics › Mirimus
Mirimus
Mirimus is a producer of custom genetically-engineered mouse models with reverse gene silencing capabilities.
Operating in biotechnology, genetics, health diagnostics, life science, oncology, pharmaceutical, therapeutics based in Greater New York Area, East Coast, Northeastern US, Mirimus was founded in 2011.
Mirimus is positioned in biotechnology, genetics, health diagnostics, life science, oncology, pharmaceutical, therapeutics, a segment that rewards a clear, focused offering.
Its base of operations is Greater New York Area, East Coast, Northeastern US.
Its current recorded stage is Grant.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $2.5M.
| Sector | Biotechnology, Genetics, Health Diagnostics, Life Science, Oncology, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Founded | 2011 |
| Employees | c_00011_00050 |
| Stage | grant |
| Total funding | $2,500,000 |
Website: www.mirimus.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account